Pharmacokinetics and antineoplastic activity of galectin-1-targeting OTX008 in combination with sunitinib

Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitors

(2015)   Oncotarget

Abstract 33: OTX008 pharmacokinetics (PK) during the first-in-man phase I study in patients with advanced solid tumors .

(2014) Keyvan Rezai et al.   CANCER RESEARCH

Polycationic calixarene PTX013, a potent cytotoxic agent against tumors and drug resistant cancer

(2013) Ruud P. M. Dings et al.   INVESTIGATIONAL NEW DRUGS

Antitumor Agent Calixarene 0118 Targets Human Galectin-1 as an Allosteric Inhibitor of Carbohydrate Binding

(2012) Ruud P. M. Dings et al.   JOURNAL OF MEDICINAL CHEMISTRY

The angiogenic process as a therapeutic target in cancer

(2011) Esther M. Bridges et al.   BIOCHEMICAL PHARMACOLOGY

Targeting angiogenesis with compounds from the extracellular matrix

(2011) Dorina Belotti et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

The Anti-angiogenic Peptide Anginex Greatly Enhances Galectin-1 Binding Affinity for Glycoproteins

(2011) Emma Salomonsson et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Molecular mechanisms and clinical applications of angiogenesis

(2011) Peter Carmeliet et al.   NATURE

Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells

(2008) S H Hsieh et al.   ONCOGENE